胸肌前与胸肌下扩张器置入对即刻假体乳房重建扩张就诊次数的影响比较
本研究比较胸肌前与胸肌下即刻假体乳房重建完成组织扩张所需就诊次数和天数。
要点
- 胸肌前组完成扩张天数更少(40.4±37.8天 vs 62.5±50.2天,P<0.001)。
- 两组轻微并发症、再入院、血清肿、血肿再手术及假体取出率无显著差异。
核心结论
- 胸肌前即刻假体乳房重建可在相似人群中以近一半的就诊次数完成更高体积扩张,且不增加并发症率。
研究设计与样本
- 单术者回顾性比较研究,纳入2016年1月至2017年7月连续接受即刻假体乳房重建伴组织扩张器的患者,分为胸肌下组(部分胸肌下/部分脱细胞真皮基质)和胸肌前组(完全脱细胞真皮基质覆盖)。
- 共101例患者(胸肌下n=69,胸肌前n=32),184侧即刻假体乳房重建(胸肌下n=124,胸肌前n=60)。
- 主要结局为完成扩张的总天数和就诊次数,采用单因素分析,显著性设定为p<0.05。
- 证据等级:治疗性,III级。
主要发现
- 两组年龄、体重指数、吸烟及糖尿病无差异(均p>0.05),随访时间相似(179.3±98.2天 vs 218.3±119.8天,p=0.115)。
- 胸肌前组最终扩张体积更大(543.7±122.9 ml vs 477.5±159.6 ml,p=0.017)。
- 两组轻微并发症(25% vs 18.5%,p=0.311)、再入院(5% vs 2.4%,p=0.393)、血清肿(8.3% vs 5.6%,p=0.489)、血肿再手术(3.3% vs 1.6%,p=0.597)及假体取出(5% vs 2.4%,p=0.393)率相似。
临床怎么用
- 对于适合即刻假体乳房重建的患者,胸肌前置入扩张器可能减少完成扩张所需的就诊次数和天数,并达到更大扩张体积,且不增加并发症。
- 临床决策时可结合患者意愿、软组织条件及随访资源,考虑胸肌前入路以优化扩张流程效率。
局限性
- 单术者回顾性比较研究,样本量有限(101例患者,184侧乳房),可能存在选择偏倚。
- 证据等级为III级,结论需更大样本前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The numerous office visits required to complete expansion in implant-based breast reconstruction impact patient satisfaction, office resources, and time to complete reconstruction. This study aimed to determine whether prepectoral compared to subpectoral immediate implant-based breast reconstruction offers expedited tissue expansion without affecting complication rates. METHODS: Consecutive patients who underwent immediate implant-based breast reconstruction with tissue expanders from January of 2016 to July of 2017 by a single surgeon were grouped into subpectoral (partial submuscular/partial acellular dermal matrix) or prepectoral (complete acellular dermal matrix coverage), and reviewed. The primary outcomes were total days and number of visits to complete expansion. Groups were compared by univariate analysis with significance set at p < 0.05. RESULTS: In total, 101 patients (subpectoral, n = 69; prepectoral, n = 32) underwent 184 immediate implant-based breast reconstructions (subpectoral, n = 124; prepectoral, n = 60). There was no difference in age, body mass index, smoking, or diabetes between the groups (all p > 0.05). Follow-up was similar between groups (179.3 ± 98.2 days versus 218.3 ± 119.8 days; p = 0.115). Prepectoral patients took fewer days to complete expansion (40.4 ± 37.8 days versus 62.5 ± 50.2 days; p < 0.001) and fewer office visits to complete expansion (2.3 ± 1 .7 versus 3.9 ± 1.8; p < 0.001), and were expanded to greater final volumes than subpectoral patients (543.7 ± 122.9 ml versus 477.5 ± 159.6 ml; p = 0.017). Between prepectoral and subpectoral reconstructions, there were similar rates of minor complications (25 percent versus 18.5 percent; p = 0.311), readmissions (5 percent versus 2.4 percent; p = 0.393), seromas (8.3 percent versus 5.6 percent; p = 0.489), reoperations for hematoma (3.3 percent versus 1.6 percent; p = 0.597), and explantations (5 percent versus 2.4 percent; p = 0.393). CONCLUSION: This novel analysis demonstrates that prepectoral immediate implant-based breast reconstruction can facilitate expansion to higher total volumes in nearly half the office visits compared to subpectoral placement in similar populations without increasing complication rates. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Wormer BA, Valmadrid AC, Ganesh Kumar N, et al. Reducing Expansion Visits in Immediate Implant-Based Breast Reconstruction: A Comparative Study of Prepectoral and Subpectoral Expander Placement. Plast Reconstr Surg. 2019. PMID: 31348326. doi:10.1097/PRS.0000000000005791
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。